J&J Consulting Group- FDA Regulatory Compliance
- 1101 California Ave Suite 100 Corona CA 92881
- Info@jjccgroup.org
- (800) 999-7781
Current Good Manufacturing Practice for Finished Pharmaceuticals
21 CFR Part 211 Regulatory Strategies for Drugs & Biologics.
Call for Appoinment
1 (800) 999-7781
FDA cGMP COMPLIANCE
Comprehensive cGMP Compliance Strategies for Drugs and Biologics Under 21 CFR Part 211
Understanding the Regulatory Landscape Achieving and maintaining cGMP compliance requires far more than meeting baseline regulatory expectations — it demands a culture of quality embedded throughout every stage of operations. Our consultants partner with drug and biologics manufacturers to design and implement comprehensive Quality Management Systems (QMS), develop robust Standard Operating Procedures (SOPs), and establish thorough documentation practices including Master Production Records, Batch Production Records, and validation protocols. We provide expert support across equipment qualification (IQ/OQ/PQ), process validation, cleaning validation, environmental monitoring, deviation management, and CAPA programs. Whether you’re commissioning a new facility, scaling commercial production, or strengthening an existing quality system, JCC Group delivers the strategic guidance and hands-on expertise needed to build operations that are both compliant and commercially efficient.
Our Services
Our 21 CFR cGMP Compliance Services
Our specialized pharmaceutical consulting services provide expert guidance in contract manufacturing oversight, CDMO selection and management, biologics compliance, cGMP training, and FDA-ready quality assurance — helping drug manufacturers achieve regulatory excellence at every stage of product development.
Facility& Equipment Compliance
Facility design review and cGMP gap assessments, Equipment qualification protocols (IQ/OQ/PQ), Cleaning validation programs, Environmental monitoring strategies, Utilities qualification (water, HVAC, compressed gases)
Process & Product Validation
Process validation (Stages 1, 2, and 3), Analytical method validation and transfer, Stability program design and management, Container closure system qualification, Continued process verification (CPV)
Quality Control & Laboratory Operations
QC laboratory cGMP compliance, Out-of-Specification (OOS) and Out-of-Trend (OOT) investigations, Reference standard and reagent management, Laboratory equipment qualification and calibration programs, Data integrity assessments (ALCOA+ principles)
- Trusted advisory relationships that evolve with your business
- Deep technical knowledge of every subpart of 21 CFR Part 211
- Decades of combined cGMP experience across pharmaceutical, biologics, and bioscience manufacturing
- Proven track record supporting startups, mid-size manufacturers
- Integrated service offerings covering QMS, validation, quality control, documentation, and training under one roof
Why choose us?
Why Partner With JJCC Group Consultants
Core Services
Our services include
We offer comprehensive support including cGMP facility setup, SOP development, process validation, audits, training, and regulatory compliance for pharmaceutical and biologic manufacturers.
Quality Management System
JCC Group delivers full-scale Quality Management System (QMS) design and implementation in compliance with 21 CFR Part 211, encompassing Standard Operating Procedure (SOP) development, master documentation frameworks, and enterprise-wide recordkeeping systems engineered to ensure regulatory alignment and operational consistency across every functional department.
Risk Mitigation & Quality Assurance
Using a proactive, risk-based approach applying ICH Q9 quality risk management frameworks and industry best practices, we help you anticipate regulatory expectations, prioritize remediation efforts, and build a culture of quality that turns compliance from a reactive obligation into a strategic advantage.
FDA Inspection Readiness
we bring the expertise, experience, and dedication needed to help pharmaceutical and biologics manufacturers build resilient, inspection-ready operations that stand up to the highest regulatory scrutiny, through mock FDA inspections that mirror real agency expectations and methodology, rapid-response remediation for Form 483 observations and Warning Letters, robust CAPA development rooted in genuine root cause analysis, and sustained audit readiness programs that prepare your team to face any regulatory visit with confidence.
Rapid Response Remedy
for form 483 observations and Warning letter response
Robust CAPA Development
rooted in genuine root cause analysis
Mock FDA inspections
that mirror real agency expectations and methodology against 21 CFR 211 for drug and Biological products
Sustained audit readiness
programs that prepare your team for any regulatory visit
cGMP READINESS
Ready to strengthen your cGMP compliance?
JJCC Group provides end-to-end support for drug and biologics manufacturers — from setup and validation to FDA inspection readiness.
Best Compliance with 5 Star
99% Happy Clients
Testimonial
What our clients say about JJCC Group
Clients trust JJCC Group for expert FDA cGMP guidance, ensuring compliant, high-quality drug and biologics manufacturing.
JJCC streamlined our cGMP compliance process, making FDA audits easier and improving overall manufacturing quality.
